正在上市关键期的宇树科技，因发明专利权纠纷被起诉。 | 案件审理流程 | | --- | | 民事一审 | | 案号：（2025）浙01知民初79号 | | 法院: 浙江省杭州市中级人民法院 | | 相关案由:侵害发明专利权纠纷 | | 原告： 杭州露韦美日化有限公司 | | 被告： 杭州宇树科技股份有限公司 | | 2025-08-26 09:30 · 开庭公告 | 记者从天眼查APP获悉，宇树科技近期新增一起司法案件纠纷。该纠纷中，原告为杭州露韦美日化有限公司（以下简称"露韦美"），被告为杭州宇树科技 股份有限公司，相关案由为侵害发明专利权纠纷。该案件将于8月26日在杭州市中级人民法院开庭审理。 公开资料显示，露韦美成立于2005年，法定代表人为周建军，注册资本55万元，是一家小微企业，主营业务包括护肤品、酒精饮料、头发护理产品，经营 范围包括食品互联网销售、食品销售、农副产品销售、日用百货销售等。露韦美有两名股东，分别为周建军和徐燕，前者持股90%，后者持股10%。同 时，公司2024年也仅有两名员工。 天眼查显示，露韦美有两条专利信息，分别是正在实质审查阶段的"一种会议同声智能系统"和已获专利授权的" ...

Market Overview - On August 4, A-shares saw collective gains across major indices, with the Shanghai Composite Index rising by 0.66% to 3583.31 points, the Shenzhen Component Index increasing by 0.46% to 11041.56 points, and the ChiNext Index up by 0.5% to 2334.32 points [2][3] - The total trading volume in the Shanghai and Shenzhen markets reached 15,182 billion yuan, a decrease of 1,017 billion yuan from the previous day, with over 3,800 stocks rising [2] Sector Performance - The humanoid robot sector showed strong performance in the afternoon, while the gaming sector was also active. The medical device sector saw a rise, but the film and theater sector mostly adjusted downwards. The retail sector lagged, and the tourism and hotel sectors experienced declines, with Tibet Tourism hitting the daily limit down [2] International Market - The U.S. stock market indices rose on August 4, with the Dow Jones Industrial Average up by 1.34% to 44,173.64 points, the S&P 500 increasing by 1.47% to 6,329.94 points, and the Nasdaq Composite rising by 1.95% to 21,053.58 points [4][6] - European stock indices also saw gains, with the UK FTSE 100 up by 0.66%, the French CAC 40 up by 1.14%, and the German DAX up by 1.42% [4] Commodity Prices - International oil prices fell on August 4, with WTI crude oil down by 1.54% to $66.29 per barrel and Brent crude down by 1.31% to $68.76 per barrel [4][5] New Developments - China has made significant progress in HIV vaccine research, completing the first phase of clinical trials for a vaccine using a modified smallpox virus as a carrier, which has shown safety and effective immune response [7] - Shanghai's government is supporting enterprises in enhancing basic research and high-quality development through the "Explorer Plan," focusing on key scientific issues in industries like integrated circuits, biomedicine, and artificial intelligence [8] - Hainan province is accelerating the development of a commercial aerospace industry chain, aiming for a revenue target of 10 billion yuan by 2027 from its aerospace cluster [9] Industry Insights - The new energy passenger vehicle wholesale sales in China reached 1.18 million units in July, marking a 25% year-on-year increase, with a cumulative total of 7.63 million units sold from January to July, up 35% year-on-year [11] - A-share new account openings approached 2 million in July, with 1.96 million new accounts opened, reflecting a significant increase compared to previous months [12] Institutional Perspectives - Huafu Securities anticipates a turning point in the building materials sector due to supply-side structural reforms and a potential recovery in housing demand, which may stabilize the real estate market [13] - Kaiyuan Securities notes that the humanoid robot sector is poised for policy benefits, with significant growth in financing and capital activities within the industry [14]

Group 1 - The core viewpoint of the news is that Ruikeda (688800) has begun small-scale supply of humanoid robot products, with expected sales revenue of approximately 10 million yuan in 2025, accounting for 0.41% of the 2024 revenue [1] - Ruikeda's stock price experienced a significant increase, with a cumulative deviation of 30% over three trading days, closing at 67.2 yuan per share on August 4, with a trading volume of 2.597 billion yuan [1] - The company emphasizes that its production and operations are normal, and there have been no significant changes, urging investors to approach market trends rationally [1] Group 2 - According to the performance forecast, Ruikeda expects a net profit attributable to shareholders of 151 million to 171 million yuan for the first half of 2025, representing a year-on-year growth of 132.44% to 163.22% [2] - The growth in performance is attributed to steady growth across various business segments, increased order volume, and advancements in technology and production automation [2] - The company is focusing on several key development areas, including 6G communication and AI data centers, automotive smart solutions, overseas market expansion, and research in humanoid robots and medical devices [2]

Core Viewpoint - Suzhou Ruikeda Connection System Co., Ltd. experienced a significant stock price fluctuation, with a cumulative increase of 30% over three consecutive trading days, prompting an inquiry into the reasons behind this abnormal trading behavior [1][2][3] Group 1: Stock Trading Abnormalities - The company's stock price increased by 30% over three trading days (July 31, August 1, and August 4, 2025), which is classified as abnormal trading behavior according to Shanghai Stock Exchange regulations [1][2] - The company conducted a self-examination and confirmed that there are no undisclosed significant matters affecting the company, and its production and operations remain normal [1][3] Group 2: Human Robot Product Development - The company has begun small-scale supply of products for humanoid robots, which are still in the early stages of industrial development [2][3] - The expected sales revenue from the humanoid robot segment for 2025 is approximately 10 million, accounting for 0.41% of the total revenue in 2024, indicating that this segment currently has a minor impact on overall performance [3] Group 3: Board of Directors' Statement - The board of directors confirmed that there are no undisclosed matters that should be reported according to the relevant regulations, including mergers, debt restructuring, or asset injections [3]

Company Announcements - Jihua Group's existing product system does not involve brain-computer interface related fields [1] - Prit's plan to invest 1 billion yuan to build a plastic modification materials headquarters and R&D manufacturing base in South China [1][2] - Lian De Equipment won a contract worth 157 million yuan for BOE's 8.6 generation AMOLED production line project [1][2] - Jiadu Technology plans to issue shares (H-shares) overseas and list on the Hong Kong Stock Exchange [1][2] - Longdi Group intends to acquire no more than 20.1667% equity in Jujia Technology [1][4] - New Zhonggang plans to repurchase shares worth 40 million to 80 million yuan [1][4] - Xiaogoods City expects a net profit increase of 12.57% to 17.40% in the first half of the year [1][4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials through block trading [1][4] - Lihua Co., Ltd. intends to reduce its holdings by no more than 3.00% [1][4] - Zhimin Da plans to raise no more than 213 million yuan through a private placement [1][5] - Xiangtong Co. plans to issue corporate bonds not exceeding 4 billion yuan [1][5] Performance Forecasts - Hanyu Pharmaceutical expects a half-year profit of 142 million to 162 million yuan, turning a profit compared to the previous year [4] - Taotao Automotive anticipates a net profit increase of 70.34% to 97.81% in the first half of the year [4] - Weichai Heavy Machinery expects a net profit increase of 40% to 60% in the first half of the year [4] Shareholding Changes - Lihua Co., Ltd.'s actual controller Cheng Lili and his concerted actors plan to reduce their holdings by no more than 3.00% [4] - He Shi Eye Hospital's Advanced Manufacturing Fund plans to reduce its holdings by no more than 2% [4] - Haitan Ruisheng's shareholder He Lin and his concerted actors plan to reduce their holdings by no more than 2.9463% [4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials [4] Other Announcements - Zhimin Da plans to raise no more than 213 million yuan through a private placement [5] - Yuyuan Co. plans to issue corporate bonds not exceeding 40 billion yuan [5] - Jinhongshun has terminated the planning of a major asset restructuring [5]